Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2023-02-01
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intravenous Ketamine and Postoperative Pain Following Cesarean Section.
NCT03018301
Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?
NCT00486902
Comparison Between Ketamine Intrathecal and iv Dexamethasone for Post Cesarean Analgesia
NCT06408974
Dose Low Dose Ketamine in Casesarian
NCT06237569
Effect of Intravenous Ketamine Infusion for Hemodynamic Stability in Patients Undergoing Caesarean Delivery.
NCT05865080
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intrathecal Ketamine
Patients will receive intrathecal Ketamine 0.1mg/kg added to bupivacaine and morphine.
Intrathecal ketamine
Patients will receive intrathecal Ketamine 0.1mg/kg added to bupivacaine and morphine
Intravenous ketamine
Patients will receive IV Ketamine 0.25mg/kg after spinal anesthesia with bupivacaine and morphine.
Intravenous ketamine
Patients will receive IV Ketamine 0.25mg/kg after spinal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intrathecal ketamine
Patients will receive intrathecal Ketamine 0.1mg/kg added to bupivacaine and morphine
Intravenous ketamine
Patients will receive IV Ketamine 0.25mg/kg after spinal
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* body mass index ≥40kg/m2, height \<150cm
* Current use of pain medication including opioids
* history of substance abuse or hallucinations, cardiovascular disease, diabetes, multiple gestations
* chronic pain was excluded.
* contraindications to spinal anaesthesia,
* severely compromised fetus requiring general anesthesia and those patients who received labor analgesia
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Youstina Tharwat Sedky
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Abd El-Rahman AM, Mohamed AA, Mohamed SA, Mostafa MAM. Effect of Intrathecally Administered Ketamine, Morphine, and Their Combination Added to Bupivacaine in Patients Undergoing Major Abdominal Cancer Surgery a Randomized, Double-Blind Study. Pain Med. 2018 Mar 1;19(3):561-568. doi: 10.1093/pm/pnx105.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ketamine in Cesarean section
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.